Skip to contentSkip to Braille Studio

Library / Laws / 115th Congress / House Resolutions / H.Res. 787

H.Res. 787

Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.

Print stageDateSize⠃
Reported in House2018-03-194.0K⠃⠗⠋
Engrossed in House2018-03-203.1K⠃⠗⠋